Department of Orthopaedics and Tumour Orthopaedics, Muenster University Hospital, Muenster, Germany.
Department of Spine Surgery, St. Franziskus-Hospital, Muenster, Germany.
Eur Spine J. 2021 May;30(5):1320-1328. doi: 10.1007/s00586-020-06689-w. Epub 2020 Dec 22.
Transforaminal lumbar interbody fusion (TLIF) is a widely accepted surgical procedure for degenerative disk disease. While numerous studies have analyzed complication rates and risk factors this study investigates the extent to which complications after TLIF spondylodesis alter the clinical outcome regarding pain and physical function.
A prospective clinical two-center study was conducted, including 157 patients undergoing TLIF spondylodesis with 12-month follow-up (FU). Our study classified complications into three subgroups: none (I), minor (IIa), and major complications (IIb). Complications were considered "major" if revision surgery was required or new permanent physical impairment ensued. Clinical outcome was assessed using visual analog scales for back (VAS-B) and leg pain (VAS-L), and Oswestry Disability Index (ODI).
Thirty-nine of 157 patients (24.8%) had at least one complication during follow-up. At FU, significant improvement was seen for group I (n = 118) in VAS-B (-50%), VAS-L (-54%), and ODI (-48%) and for group IIa (n = 27) in VAS-B (-40%), VAS-L (-64%), and ODI (-47%). In group IIb (n = 12), VAS-B (-22%, P = 0.089) and ODI (-33%, P = 0.056) improved not significantly, while VAS-L dropped significantly less (-32%, P = 0.013) compared to both other groups.
Our results suggest that major complications with need of revision surgery after TLIF spondylodesis lead to a significantly worse clinical outcome (VAS-B, VAS-L, and ODI) compared to no or minor complications. It is therefore vitally important to raise the surgeon´s awareness of consequences of major complications, and the topic should be given high priority in clinical work.
经椎间孔腰椎体间融合术(TLIF)是一种广泛应用于治疗退行性椎间盘疾病的手术方法。虽然已有大量研究分析了并发症发生率和危险因素,但本研究旨在探讨 TLIF 融合术后并发症对疼痛和身体功能等临床结果的影响程度。
进行了一项前瞻性的临床双中心研究,共纳入 157 例接受 TLIF 融合术的患者,随访时间为 12 个月。我们将并发症分为三组:无并发症(I 组)、轻微并发症(IIa 组)和严重并发症(IIb 组)。如果需要再次手术或出现新的永久性身体功能障碍,则认为并发症为“严重”。采用视觉模拟评分(VAS)评估背部(VAS-B)和腿部疼痛(VAS-L),采用 Oswestry 残疾指数(ODI)评估临床结果。
157 例患者中有 39 例(24.8%)在随访期间至少发生了 1 种并发症。在随访结束时,I 组(n=118)的 VAS-B(-50%)、VAS-L(-54%)和 ODI(-48%)显著改善,IIa 组(n=27)的 VAS-B(-40%)、VAS-L(-64%)和 ODI(-47%)也显著改善。然而,在 IIb 组(n=12)中,VAS-B(-22%,P=0.089)和 ODI(-33%,P=0.056)的改善不显著,而 VAS-L 的下降程度明显低于其他两组(-32%,P=0.013)。
我们的研究结果表明,TLIF 融合术后需要再次手术的严重并发症会导致临床结果(VAS-B、VAS-L 和 ODI)明显恶化,与无并发症或轻微并发症相比差异具有统计学意义。因此,提高外科医生对严重并发症后果的认识至关重要,在临床工作中应高度重视这一问题。